Jackson J A, Kleerekoper M, Parfitt A M, Rao D S, Villanueva A R, Frame B
J Clin Endocrinol Metab. 1987 Jul;65(1):53-8. doi: 10.1210/jcem-65-1-53.
We present iliac bone histomorphometric data after in vivo double tetracycline labeling and related biochemical data from 14 nonalcoholic men referred for evaluation of symptomatic spinal osteoporosis. Six patients had previously undiagnosed hypogonadism, and 8 had normal gonadal function and no evident etiology for osteoporosis. Bone histomorphometry revealed no differences in structural measurements or resorption indices between the 2 groups. However, compared to reference values for normal postmenopausal women, osteoblast surface, mineralizing surface, and formation rate were normal or modestly increased in the hypogonadal men and significantly reduced in the idiopathic group. There were significant corresponding differences between the 2 groups in the fasting urinary hydroxyproline to creatinine ratio, an index of bone resorption, and serum total alkaline phosphatase, an index of bone formation. Plasma 25-hydroxyvitamin D levels did not differ between the 2 groups and were above 10 ng/mL in all patients. Plasma 1,25-dihydroxyvitamin D [1,25-(OH)2D] levels were normal in the hypogonadal group and significantly reduced in the idiopathic group, but did not correlate with any histological measurements. The formation indices fell substantially in 3 of 4 hypogonadal men after 7-14 months of therapy with testosterone and a calcium supplement. We conclude the following. In vitamin D-replete hypogonadal men with osteoporosis, 1,25-(OH)2D synthesis is normal, and bone remodeling is modestly increased and correctable by hormone replacement therapy, as in normal postmenopausal women. In middle-aged men with idiopathic osteoporosis, there is impairment of 1,25-(OH)2D synthesis and of the recruitment and activity of teams of osteoblasts, as in postmenopausal osteoporosis.
我们展示了14名因有症状的脊柱骨质疏松症前来评估的非酒精性男性在体内进行双四环素标记后的髂骨组织形态计量学数据以及相关生化数据。6名患者此前未被诊断出性腺功能减退,8名患者性腺功能正常且无明显的骨质疏松病因。骨组织形态计量学显示两组在结构测量或吸收指数方面没有差异。然而,与正常绝经后女性的参考值相比,性腺功能减退男性的成骨细胞表面、矿化表面和形成率正常或略有增加,而特发性组则显著降低。两组在空腹尿羟脯氨酸与肌酐比值(骨吸收指标)和血清总碱性磷酸酶(骨形成指标)方面存在显著的相应差异。两组间血浆25-羟维生素D水平无差异,所有患者均高于10 ng/mL。性腺功能减退组血浆1,25-二羟维生素D [1,25-(OH)2D]水平正常,特发性组显著降低,但与任何组织学测量均无相关性。4名性腺功能减退男性中有3名在接受睾酮和钙补充剂治疗7 - 14个月后,形成指数大幅下降。我们得出以下结论。在维生素D充足的性腺功能减退性骨质疏松男性中,1,25-(OH)2D合成正常,骨重塑略有增加且可通过激素替代疗法纠正,如同正常绝经后女性。在患有特发性骨质疏松症的中年男性中,1,25-(OH)2D合成以及成骨细胞团队的募集和活性受损,如同绝经后骨质疏松症。